GW Pharmaceuticals (GW) was founded in 1998 and is listed on the NASDAQ Stock Market (GWPH). The company is headquartered in the UK and has operations in the US and continental Europe. GW has established itself as a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Share this Blog Post: